Furthermore, similar as to the ESC miRNA signature, ESC mRNA signature scores are related to survival in a global cohort of neuroblastoma tumors, but also in a subgroup of stage 4 tumors without MYCN amplification (Supplemental Fig. 2A–D). Here, MYCN is linked to neuroblastoma.